Public health. Optimizing investments in malaria treatment and diagnosis

Science. 2012 Nov 2;338(6107):612-4. doi: 10.1126/science.1229045.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Age Factors
  • Antimalarials / economics
  • Antimalarials / supply & distribution*
  • Antimalarials / therapeutic use*
  • Artemisinins / supply & distribution
  • Artemisinins / therapeutic use
  • Child
  • Child, Preschool
  • Cost-Benefit Analysis
  • Drug Therapy, Combination
  • Fever / etiology
  • Health Policy
  • Health Services Accessibility
  • Humans
  • International Cooperation
  • Lactones / supply & distribution
  • Lactones / therapeutic use
  • Malaria / diagnosis*
  • Malaria / drug therapy*
  • Malaria / epidemiology
  • Malaria, Falciparum / diagnosis*
  • Malaria, Falciparum / drug therapy*
  • Malaria, Falciparum / epidemiology
  • Prevalence
  • Private Sector
  • Public Health
  • Public-Private Sector Partnerships

Substances

  • Antimalarials
  • Artemisinins
  • Lactones
  • artemisin